Physicians and Professionals

Cardiola LTD., based in Switzerland, has developed a completely new and highly-effective option for treating indications of chronic heart failure.

The Muscular Counter Pulsation method (MCP) opens up entirely new therapy options for cardiologists and physicians through all stages of heart failure – especially for patients who are not eligible or do not respond satisfactorily to current treatments.

Muscular Counter Pulsation (MCP) 

• reduces afterload and improves hemodynamics
• leads to a considerable increase in performance and thus a clear improvement in the quality of life  
• can be used alone or in combination with other therapies

The following pages provide detailed information on the innovative technology of Muscular Counter Pulsation (MCP) and summarize the clinical results.